← Back to headlines
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here’s Why
TD Cowen has raised its price target for Royalty Pharma Plc (RPRX) from $45 to $50, providing reasons for the increase.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
Related Stories
Hedge Fund Sagefield Capital Initiated a Position in CSG Systems Worth $20.8 Million. Is the Stock a Buy?
18m ago
American Electric Power (AEP) Gets Price Target Hikes from Evercore ISI and Argus
18m ago
1 Vanguard ETF I Keep Buying Every Time the Market Dips
21m ago
SSNIT Assets Reach GH¢25 Billion Amidst Calls for Pension Literacy
23m ago